Pressure BioSciences, Inc. to Discuss Second Quarter Financial Results and Provide Business Update

WEST BRIDGEWATER, Mass., Aug. 8 /PRNewswire-FirstCall/ -- Pressure BioSciences, Inc. (Nasdaq: PBIO) today announced that the Company will host a teleconference to discuss its second quarter 2007 financial results and to provide a business update. The teleconference information provided below:

    Date: Tuesday, August 14, 2007
    Time: 4:00 p.m. Eastern time

    To attend this teleconference via web-cast go to:
    http://www.pressurebiosciences.com

    To attend this teleconference via telephone, dial:
    Dial-in: 800-616-9004
    Participant code: 9924786

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. (PBI) is a publicly-traded company focused on the development of a novel, enabling technology called Pressure Cycling Technology (PCT). PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (up to 35,000 psi and greater) to control bio-molecular interactions. PBI currently holds 13 US and 5 foreign patents covering multiple applications of PCT in the life sciences field, including such areas as genomic and proteomic sample preparation, pathogen inactivation, the control of enzymes, immunodiagnostics, and protein purification.

Investor Contacts:

    Richard T. Schumacher, President & CEO           PressureBioSciences, Inc.

Edward H. Myles, Senior Vice President of Finance & CFO (T) 508-580-1818

SOURCE Pressure BioSciences, Inc

Released August 8, 2007